BridgeBio Pharma, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsAug 31 →InsidersNo open-market buys. 10 insiders sold $101.0M, 145 of 151 sales on a 10b5-1 plan.→HoldersJupiter Topco 7.2%Kohlberg Kravis Roberts & 6.8%Farallon 5.5%→Financing →PeersClosest companies: ROIV, VRDN, MREO→
From the filings
Figures
- Revenue
- $713.1Mlast 12 months
- Net income
- −$702.0Mlast 12 months
- Operating cash flow
- −$444.0Mlast 12 months
- Cash and equivalents
- $677.9Mat the last balance sheet
- Total debt
- $2.65Bat the last balance sheet
- Shares outstanding
- 195.3M shareson issue